Imagion Biosystems Limited Stock Gross Profit

IBXXF Stock  USD 0.04  0.00  0.00%   
Imagion Biosystems Limited fundamentals help investors to digest information that contributes to Imagion Biosystems' financial success or failures. It also enables traders to predict the movement of Imagion Pink Sheet. The fundamental analysis module provides a way to measure Imagion Biosystems' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Imagion Biosystems pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Imagion Biosystems Limited Company Gross Profit Analysis

Imagion Biosystems' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

 = 

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current Imagion Biosystems Gross Profit

    
  151.53 K  
Most of Imagion Biosystems' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Imagion Biosystems Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition

According to the company disclosure, Imagion Biosystems Limited reported 151.53 K of gross profit. This is 99.99% lower than that of the Healthcare sector and 99.98% lower than that of the Diagnostics & Research industry. The gross profit for all United States stocks is 100.0% higher than that of the company.

Imagion Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Imagion Biosystems' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Imagion Biosystems could also be used in its relative valuation, which is a method of valuing Imagion Biosystems by comparing valuation metrics of similar companies.
Imagion Biosystems is currently under evaluation in gross profit category among its peers.

Imagion Fundamentals

About Imagion Biosystems Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Imagion Biosystems Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Imagion Biosystems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Imagion Biosystems Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Imagion Pink Sheet

Imagion Biosystems financial ratios help investors to determine whether Imagion Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Imagion with respect to the benefits of owning Imagion Biosystems security.